Swiss researchers have suspended testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects.

The World Health Organisation said it expects to begin small-scale use of two experimental ebola vaccines in West Africa early next year and in the meantime, transfusions of survivors’ blood may offer the best hope of treatment.